BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2903016)

  • 1. Distribution of [3H]diisopropylfluorophosphate, [3H]soman, [3H]sarin, and their metabolites in mouse brain.
    Little PJ; Scimeca JA; Martin BR
    Drug Metab Dispos; 1988; 16(4):515-20. PubMed ID: 2903016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition of [3H]diisopropylfluorophosphate in guinea pigs after inhalation.
    Scimeca JA; Martin BR
    Drug Metab Dispos; 1988; 16(4):534-9. PubMed ID: 2903019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
    Tripathi HL; Dewey WL
    J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents.
    Shih ML; McMonagle JD; Dolzine TW; Gresham VC
    J Appl Toxicol; 1994; 14(3):195-9. PubMed ID: 8083481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP).
    Little JS; Broomfield CA; Fox-Talbot MK; Boucher LJ; MacIver B; Lenz DE
    Biochem Pharmacol; 1989 Jan; 38(1):23-9. PubMed ID: 2910306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue disposition of [3H]sarin and its metabolites in mice.
    Little PJ; Reynolds ML; Bowman ER; Martin BR
    Toxicol Appl Pharmacol; 1986 May; 83(3):412-9. PubMed ID: 3705071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
    Fernando JC; Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of some organophosphorus compounds at adenosine receptors in guinea pig brain membranes.
    Lau WM; Freeman SE; Szilagyi M
    Neurosci Lett; 1988 Nov; 94(1-2):125-30. PubMed ID: 3241661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice.
    Reynolds ML; Little PJ; Thomas BF; Bagley RB; Martin BR
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):409-20. PubMed ID: 4035696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats.
    Sivam SP; Hoskins B; Ho IK
    Fundam Appl Toxicol; 1984 Aug; 4(4):531-8. PubMed ID: 6479498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodisposition of [3H]diisopropylfluorophosphate in mice.
    Martin BR
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):275-84. PubMed ID: 3975900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nimodipine on elimination of soman in rabbit blood and distribution of [3H]soman in mice.
    Li JT; Ruan JX; Yuan SL; Zhang ZQ; Song ZY; Wang XY
    Acta Pharmacol Sin; 2002 Oct; 23(10):937-41. PubMed ID: 12370099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarin-like and soman-like organophosphorous agents activate PLCgamma in rat brains.
    Niijima H; Nagao M; Nakajima M; Takatori T; Matsuda Y; Iwase H; Kobayashi M
    Toxicol Appl Pharmacol; 1999 Apr; 156(1):64-9. PubMed ID: 10101100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobehavioral toxicity with low doses of sarin and soman.
    Sirkka U; Nieminen SA; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):245-50. PubMed ID: 2374471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of 2-PAM plasma levels after organophosphate intoxication.
    Green MD; Reid F; Kaminskis A
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):255-66. PubMed ID: 4059652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry identifies covalent binding of soman, sarin, chlorpyrifos oxon, diisopropyl fluorophosphate, and FP-biotin to tyrosines on tubulin: a potential mechanism of long term toxicity by organophosphorus agents.
    Grigoryan H; Schopfer LM; Thompson CM; Terry AV; Masson P; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):180-6. PubMed ID: 18502412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between cholinesterase activity and acetylcholine of the brains of mice acutely intoxicated with soman].
    Zhang X; Qin BY
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):16-9. PubMed ID: 3158152
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissociation of locomotor depression and ChE activity after DFP, soman and sarin.
    Lynch MR; Rice MA; Robinson SE
    Pharmacol Biochem Behav; 1986 Apr; 24(4):941-7. PubMed ID: 3714785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the pharmacological effects and the biodisposition of [3H]diisopropylfluorophosphate in mice after inhalation.
    Scimeca JA; Little PJ; Martin BR
    Toxicol Appl Pharmacol; 1985 Jul; 79(3):502-10. PubMed ID: 4035691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.